BIOXYTRAN, INC financial data

Symbol
BIXT on OTC
Location
Needham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.26% % -79%
Return On Equity 94% % -47%
Return On Assets -1627% % 19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99,103,873 shares 16%
Common Stock, Shares, Outstanding 88,992,243 shares 8.2%
Entity Public Float $8,002,442 USD -13%
Common Stock, Value, Issued $88,992 USD 8.2%
Weighted Average Number of Shares Outstanding, Basic 88,992,242 shares -30%
Weighted Average Number of Shares Outstanding, Diluted 88,992,242 shares -30%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $102,500 USD
General and Administrative Expense $647,991 USD -28%
Operating Income (Loss) $1,723,539 USD 37%
Nonoperating Income (Expense) $629,523 USD -328%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,353,062 USD 16%
Net Income (Loss) Attributable to Parent $2,353,061 USD 15%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $14,499 USD -58%
Assets $156,294 USD -1.7%
Liabilities, Current $3,060,937 USD 146%
Liabilities $3,060,937 USD 146%
Retained Earnings (Accumulated Deficit) $20,522,092 USD -12%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,904,643 USD -168%
Liabilities and Equity $156,294 USD -1.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $167,323 USD -53%
Net Cash Provided by (Used in) Financing Activities $166,532 USD 67%
Net Cash Provided by (Used in) Investing Activities $5,995 USD -27%
Common Stock, Shares Authorized 400,000,000 shares 33%
Common Stock, Shares, Issued 88,992,243 shares 8.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities $163,562 USD 212%
Deferred Tax Assets, Valuation Allowance $3,276,000 USD 19%
Deferred Tax Assets, Gross $3,276,000 USD 19%
Deferred Tax Assets, Operating Loss Carryforwards $15,600,000 USD 19%
Preferred Stock, Shares Issued 43,429,639 shares 50%
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Additional Paid in Capital $17,471,675 USD
Preferred Stock, Shares Outstanding 43,429,639 shares 50%
Amortization of Intangible Assets $11,463 USD 29%
Share-based Payment Arrangement, Expense $28,600 USD -90%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%